231 related articles for article (PubMed ID: 17033807)
21. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
Friedman KG; Gauvreau K; Baker A; Son MB; Sundel R; Dionne A; Giorgio T; De Ferranti S; Newburger JW
Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
[TBL] [Abstract][Full Text] [Related]
22. Intravenous gamma-globulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
[TBL] [Abstract][Full Text] [Related]
23. [Review and analysis of 283 cases of Kawasaki disease].
Wang L; Lin Y; Su YZ; Wang Y; Zhao D; Wu TJ
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):609-12. PubMed ID: 15347450
[TBL] [Abstract][Full Text] [Related]
24. Predicting IVIG resistance in UK Kawasaki disease.
Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
[TBL] [Abstract][Full Text] [Related]
25. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease.
Morikawa Y; Ohashi Y; Harada K; Asai T; Okawa S; Nagashima M; Katoh T; Baba K; Furusho K; Okuni M; Osano M
Pediatr Int; 2000 Oct; 42(5):464-9. PubMed ID: 11059532
[TBL] [Abstract][Full Text] [Related]
26. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
[TBL] [Abstract][Full Text] [Related]
27. Kawasaki disease in Oman--a clinical study.
Bhatnagar SK; Paul G; Subramanian R; Al Hosni MS; Al Khusaiby SM
J Trop Pediatr; 2003 Dec; 49(6):361-6. PubMed ID: 14725413
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
Tang Y; Yan W; Sun L; Xu Q; Ding Y; Lv H
Clin Rheumatol; 2018 Jul; 37(7):1945-1951. PubMed ID: 29330741
[TBL] [Abstract][Full Text] [Related]
29. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
Tajima M; Shiozawa Y; Kagawa J
Pediatr Cardiol; 2015 Aug; 36(6):1159-65. PubMed ID: 25753685
[TBL] [Abstract][Full Text] [Related]
30. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
[TBL] [Abstract][Full Text] [Related]
31. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
[TBL] [Abstract][Full Text] [Related]
32. Delayed diagnosis of Kawasaki disease: risk factors and outcome of treatment.
Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
Ann Trop Paediatr; 2011; 31(2):109-14. PubMed ID: 21575314
[TBL] [Abstract][Full Text] [Related]
33. Macrophage migration inhibitory factor -173 polymorphism and risk of coronary alterations in children with Kawasaki disease.
Simonini G; Corinaldesi E; Massai C; Falcini F; Fanti F; De Martino M; Cimaz R
Clin Exp Rheumatol; 2009; 27(6):1026-30. PubMed ID: 20149326
[TBL] [Abstract][Full Text] [Related]
34. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
Pediatr Infect Dis J; 2023 Jul; 42(7):608-613. PubMed ID: 37053581
[TBL] [Abstract][Full Text] [Related]
35. [Kawasaki disease in children--9 years experience].
Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
[TBL] [Abstract][Full Text] [Related]
36. Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children.
Yi DY; Kim JY; Choi EY; Choi JY; Yang HR
BMC Pediatr; 2014 Feb; 14():51. PubMed ID: 24548331
[TBL] [Abstract][Full Text] [Related]
37. Management of Kawasaki disease in the British Isles.
Dhillon R; Newton L; Rudd PT; Hall SM
Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
[TBL] [Abstract][Full Text] [Related]
38. Kawasaki disease in Thai infants compared with older children.
Sittiwangkul R; Pongprot Y; Thongsongkrit W; Silvilairat S; Phornphutkul C
Ann Trop Paediatr; 2004 Mar; 24(1):59-63. PubMed ID: 15005968
[TBL] [Abstract][Full Text] [Related]
39. Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae.
Yanagawa H; Nakamura Y; Sakata K; Yashiro M
Pediatr Cardiol; 1997; 18(1):19-23. PubMed ID: 8960487
[TBL] [Abstract][Full Text] [Related]
40. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
